News Biogen takes on Tecfidera adherence issues Company hopes to coach patients with stomach side-effects.
News Celgene baffles market with Crohn's drug data Analysts left guessing from snippet of early phase data.
News Shire buys rights to Pfizer gastrointestinal drug Shire has bought rights to PF-00547659 for an undisclosed sum.
News Biosimilar switching not suitable for all patients Antibodies against originator will also target biosimilar.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.